GH1 and obesity due to melanocortin 4 receptor deficiency: Concerning our patient, no noticeable risk factors for cancer, such as obesity, a previous primary malignancy before starting GH treatment, or a suspected genetic predisposition, have been revealed according to the underlying syndrome.